The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis

被引:31
|
作者
da Silva Filho, Luiz Vicente F.
Tateno, Adriana F.
Martins, Katia M.
Azzuz Chernishev, Ana Carolina
Garcia, Doroti De Oliveira
Haug, Maria
Meisner, Christoph
Rodrigues, Joaquim C.
Doering, Gerd
机构
[1] Inst Crianca, HC FMUSP, Pediat Pulmonol Unit, BR-05450001 Sao Paulo, Brazil
[2] Univ Sao Paulo, Hosp & Clin, Sch Med, Inst Crianca, Sao Paulo, Brazil
[3] Adolfo Lutz Inst, Bacteriol Sect, Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Med, Inst Trop Med, Virol Lab, Sao Paulo, Brazil
[5] Univ Klinikum Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany
[6] Univ Klinikum Tubingen, Inst Med Informat Proc, Tubingen, Germany
关键词
cystic fibrosis; Pseudomonas aeruginosa; serology; PCR; microbiology;
D O I
10.1002/ppul.20686
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Early diagnosis of Pseudomonas aeruginosa colonization/infection in patients with cystic fibrosis (CF) using microbiological culturing methods maybe difficult. Serology and polymerase chain reaction (PCR) may be useful techniques for early detection of P. aeruginosa in children with CE Methods: A cross-sectional analysis comparing results obtained by three different methods for P. aeruginosa identification was performed in 87 CF patients with a mean age of 9.7 years. Microbiological culturing and PCR targeting the algD GDP mannose dehydrogenase gene of P. aeruginosa were performed in sputum or oropharyngeal swabs samples, and serum antibodies against three P. aeruginosa antigens (elastase, alkaline protease, and exotoxin A) were assessed once. Results: It was possible to isolate P. aeruginosa by culture in samples from 42 patients (48.2%), while PCR was positive in 53 (60.9%) patients. Serology was positive in 38 patients (43.6%), with a higher positivity for elastase (37.9%), followed by alkaline protease (29.9%) and exotoxin A (19.5%). The difference among the three isolated methods was not statistically significant. The combination of PCR + serology was significantly superior to single methods, to PCR + culture and also to culture + serology Conclusions: PCR identified a higher number of patients with P. aeruginosa than serology and conventional culture, but the difference did not reach statistical significance. Any of the combination methods that included PCR resulted in significantly statistical differences in relation to isolated microbiological or serology methods, but not to the PCR method alone, suggesting that PCR may be the main additive method for P. aeruginosa identification.
引用
收藏
页码:938 / 944
页数:7
相关论文
共 50 条
  • [41] Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection
    J E Park
    R Yung
    D Stefanowicz
    K Shumansky
    L Akhabir
    P R Durie
    M Corey
    J Zielenski
    R Dorfman
    D Daley
    A J Sandford
    Genes & Immunity, 2011, 12 : 370 - 377
  • [42] Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection
    Park, J. E.
    Yung, R.
    Stefanowicz, D.
    Shumansky, K.
    Akhabir, L.
    Durie, P. R.
    Corey, M.
    Zielenski, J.
    Dorfman, R.
    Daley, D.
    Sandford, A. J.
    GENES AND IMMUNITY, 2011, 12 (05) : 370 - 377
  • [43] Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
    Bilton, Diana
    Pressler, Tacjana
    Fajac, Isabelle
    Clancy, John Paul
    Sands, Dorota
    Minic, Predrag
    Cipolli, Marco
    Galeva, Ivanka
    Sole, Amparo
    Quittner, Alexandra L.
    Liu, Keith
    McGinnis, John R., II
    Eagle, Gina
    Gupta, Renu
    Konstan, Michael W.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (02) : 284 - 291
  • [44] Novel conjugate vaccine for the prevention of pseudomonas aeruginosa infection in cystic fibrosis patients
    Matson, Kelly L.
    Bratberg, Jeffrey P.
    DRUG DEVELOPMENT RESEARCH, 2007, 68 (08) : 512 - 521
  • [45] Conditions Associated with the Cystic Fibrosis Defect Promote Chronic Pseudomonas aeruginosa Infection
    Staudinger, Benjamin J.
    Muller, Jocelyn Fraga
    Halldorsson, Skarpheoinn
    Boles, Blaise
    Angermeyer, Angus
    Dao Nguyen
    Rosen, Henry
    Baldursson, Olafur
    Gottfreosson, Magnus
    Guomundsson, Guomundur Hrafn
    Singh, Pradeep K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (07) : 812 - 824
  • [46] Factors influencing the acquisition and eradication of early Pseudomonas aeruginosa infection in cystic fibrosis
    Jackson, Lindsay
    Waters, Valerie
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 8 - 16
  • [47] DIAGNOSIS OF CHRONIC PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS BY ELISA FOR ANTIPSEUDOMONAS LPS IGG ANTIBODIES
    NELSON, JW
    BARCLAY, GR
    GOVAN, JRW
    SERODIAGNOSIS AND IMMUNOTHERAPY IN INFECTIOUS DISEASE, 1990, 4 (01) : 9 - 16
  • [48] To bead or not to bead: A review of Pseudomonas aeruginosa lung infection models for cystic fibrosis
    Reyne, Nicole
    McCarron, Alexandra
    Cmielewski, Patricia
    Parsons, David
    Donnelley, Martin
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [49] Porphyromonas, a potential predictive biomarker of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis
    Keravec, Marlene
    Mounier, Jerome
    Guilloux, Charles-Antoine
    Fangous, Marie-Sarah
    Mondot, Stanislas
    Vallet, Sophie
    Gouriou, Stephanie
    Le Berre, Rozenn
    Rault, Gilles
    Ferec, Claude
    Barbier, Georges
    Lepage, Patricia
    Hery-Arnaud, Genevieve
    BMJ OPEN RESPIRATORY RESEARCH, 2019, 6 (01)
  • [50] Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients
    Ehsan, Zarmina
    Wetzel, Jacqueline Denise
    Clancy, John P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 743 - 749